SpringerLink
Log in

High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders

  • Letter to the Editor
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peñas-LLedó E, Dorado P, Agüera Z, Gratacós M, Estivill X, Fernández-Aranda F et al. Pharmacogenomics J; published online 28 September 2010 [e-pub ahead of print].

  2. Zackrisson AL, Lindblom B, Ahlner J . Clin Pharmacol Ther 2010; 88: 354–359.

    Article  CAS  Google Scholar 

  3. LLerena A, Dorado P, Peñas-Lledó EM . Pharmacogenomics 2009; 10: 17–28.

    Article  CAS  Google Scholar 

  4. Kawanishi C, Lundgren S, Agren H, Bertilsson L . Eur J Clin Pharmacol 2004; 59: 803–807.

    Article  CAS  Google Scholar 

  5. Peñas-LLedó EM, Dorado P, Pacheco R, González I, LLerena A . Pharmacogenomics 2009; 10: 1111–1120.

    Article  Google Scholar 

Download references

Acknowledgements

This study was partially supported by grants from Instituto de Salud Carlos III (ISCIII)-FIS Junta de Extremadura and European Union-FEDER BS10023, PI10/02785, PI081714 and CP06/00030 (Pedro Dorado). CIBER is an initiative of ISCIII (Spain). This study was coordinated within the network Red Iberoamericana de Farmacogenética y Farmacogenómica (http://www.ribef.com).

Author information

Authors and Affiliations

  1. CICAB Clinical Research Center, Extremadura University Hospital Medical School, and CIBERSAM, Badajoz, Spain

    E M Peñas-Lledó, P Dorado & A LLerena

  2. Department of Psychiatry, University Hospital of Bellvitge-IDIBELL and Ciber Fisiopatologia Obesidad y Nutrición (CIBEROBN), Instituto Salud Carlos III, Barcelona, Spain

    Z Agüera & F Fernández-Aranda

  3. CIBER en Epidemiología y Salud Pública (CIBERESP), Genes and Disease Program, Center for Genomic Regulation (CRG-UPF), Barcelona, Spain

    M Gratacós & X Estivill

  4. Department of Clinical Sciences, University of Barcelona, Barcelona, Spain

    F Fernández-Aranda

Authors
  1. E M Peñas-Lledó
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Dorado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z Agüera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Gratacós
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. X Estivill
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Fernández-Aranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A LLerena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to F Fernández-Aranda or A LLerena.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peñas-Lledó, E., Dorado, P., Agüera, Z. et al. High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders. Mol Psychiatry 16, 691–692 (2011). https://doi.org/10.1038/mp.2011.5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2011.5

  • Springer Nature Limited

Search

Navigation